Frontier Biosecurity Policy Evaluator

Simulate the bipartisan legislative push backed by OpenAI to restrict synthetic pathogen generation, require DNA order screening, and mandate frontier model red-teaming against chemical & biological threats.

Policy Status

Policy Safeguards Active

Coverage Score

89%

Residual Risk

Low-Moderate

Legislative Provisions & Lab Standards

Toggle policy levers to simulate legal compliance, laboratory verification hurdles, and AI provider commitments.

DNA Synthesis Customer Screening Pathogen Defense

Mandate all gene-synthesis providers screen customer identities and sequence orders against CDC select agents and toxic virulence factors.

Dual-Use Biological Research Oversight Federal Audit

Establish federal pre-release red teaming requirements for foundation models capable of agent-level wet-lab protocol generation.

Cloud Compute Know-Your-Customer (KYC) Compute Guard

Require hyperscale GPU clouds to verify foreign entities training or fine-tuning biology-specialized AI checkpoints.

Voluntary Lab Commitments & Biosafety Evals Self-Regulation

Frontier AI labs proactively halt fine-tuning runs that demonstrate automated aerosolization or evasion design enhancements.

Export Restrictions on Advanced Bio-AI Models National Security

Classify protein folding and viral redesign specialized models under EAR dual-use commerce restrictions.

Stakeholder Alignment Index: 84% (Bipartisan Consensus)

Threat Mitigation Radar & Vector Analysis Safeguards Engaged

Vector Mitigation Deficits

Live Safeguard Artifact Preview

Loading compliance data...